BTIG analyst Mark Massaro upgraded CareDx to Buy from Neutral with a $40 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDNA:
- CareDx price target raised to $40 from $32 at Craig-Hallum
- CareDx price target raised to $32 from $22 at Craig-Hallum
- CareDx raises FY24 revenue view to $320M-$328M, consensus $278.96M
- CareDx reports Q2 adjusted EPS 25c, consensus (14c)
- CDNA Earnings Report this Week: Is It a Buy, Ahead of Earnings?